Papi C - Search Results

1

Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications.

Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, Koch M, Capurso L. Papi C, et al. Dig Liver Dis. 2005 Apr;37(4):247-53. doi: 10.1016/j.dld.2004.10.012. Epub 2005 Jan 8. Dig Liver Dis. 2005. PMID: 15788208

2

Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.

Papi C, Ciaco A, Koch M, Capurso L. Papi C, et al. Ital J Gastroenterol. 1992 Oct;24(8):452-6. Ital J Gastroenterol. 1992. PMID: 1330083 Clinical Trial.

3

[Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].

Ciaco A, Papi C, Capurso L. Ciaco A, et al. Among authors: papi c. Minerva Gastroenterol Dietol. 1992 Jul-Sep;38(3):153-9. Minerva Gastroenterol Dietol. 1992. PMID: 1363719 Clinical Trial. Italian.

4

Severe ulcerative colitis, dural sinus thrombosis, and the lupus anticoagulant.

Papi C, Ciaco A, Acierno G, Di Battista G, Talamanca LF, Lo Russo F, Natali G, Capurso L. Papi C, et al. Am J Gastroenterol. 1995 Sep;90(9):1514-7. Am J Gastroenterol. 1995. PMID: 7661181

5

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial.

Papi C, Ciaco A, Koch M, Capurso L. Papi C, et al. Aliment Pharmacol Ther. 1995 Feb;9(1):33-9. doi: 10.1111/j.1365-2036.1995.tb00348.x. Aliment Pharmacol Ther. 1995. PMID: 7766741 Clinical Trial.

6

Correlation of various Crohn's disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics.

Papi C, Ciaco A, Bianchi M, Montanti S, Koch M, Capurso L. Papi C, et al. J Clin Gastroenterol. 1996 Jul;23(1):40-3. doi: 10.1097/00004836-199607000-00011. J Clin Gastroenterol. 1996. PMID: 8835898

7

Acute ischaemic colitis following intravenous cocaine use.

Papi C, Candia S, Masci P, Ciaco A, Montanti S, Capurso L. Papi C, et al. Ital J Gastroenterol Hepatol. 1999 May;31(4):305-7. Ital J Gastroenterol Hepatol. 1999. PMID: 10425576

8

Budesonide in the treatment of Crohn's disease: a meta-analysis.

Papi C, Luchetti R, Gili L, Montanti S, Koch M, Capurso L. Papi C, et al. Aliment Pharmacol Ther. 2000 Nov;14(11):1419-28. doi: 10.1046/j.1365-2036.2000.00867.x. Aliment Pharmacol Ther. 2000. PMID: 11069312 Free article.

9

Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study.

Viscido A, Bagnardi V, Sturniolo GC, Annese V, Frieri G, D'Arienzo A, Papi C, Riegler G, Corrao G, Caprilli R; GISC: Italian Group for the Study of the Colon and Rectum. Viscido A, et al. Among authors: papi c. Dig Liver Dis. 2001 Nov;33(8):686-92. doi: 10.1016/s1590-8658(01)80046-3. Dig Liver Dis. 2001. PMID: 11785715

10

Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage.

Papi C, Gili L, Tarquini M, Antonelli G, Capurso L. Papi C, et al. J Clin Gastroenterol. 2003 Mar;36(3):238-41. doi: 10.1097/00004836-200303000-00011. J Clin Gastroenterol. 2003. PMID: 12590236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters